Search results
Results From The WOW.Com Content Network
The Sanofi–GSK COVID‑19 vaccine is a recombinant protein subunit vaccine containing the SARS-CoV-2 spike protein, which is produced in insect cells via a baculovirus vector. It also includes an adjuvant made by GSK. It uses the same technology as Sanofi's Flublok influenza vaccine. [ 7][ 8]
GSK plc (76.5%) Pfizer (13.5%) Shionogi (10%) Number of employees. c. 1,100 (2023) Website. viivhealthcare .com. ViiV Healthcare ( / ˈviːv / VEEV) is a British multinational pharmaceutical company specializing in the research and development of medicines to treat and prevent HIV/AIDS. Its global headquarters is located in London.
GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK. [4] [5] The company's product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology ...
The vaccines are the first approved to prevent RSV, which causes around 14,000 deaths in adults aged 65 and older in the U.S. annually, according to government estimates. US CDC OKs use of new ...
In April, Pfizer said its vaccine succeeded in a trial evaluating it in adults under age 60, adding that it plans to submit for expanded approval of the vaccine in adults aged 18 to 59. GSK also ...
July 26, 2024 at 4:12 AM. (Reuters) -The European Union health regulator on Friday recommended expanded use of GSK's respiratory syncytial virus (RSV) vaccine in adults aged between 50 and 59. Any ...
AS03 (for "Adjuvant System 03") is the trade name for a squalene -based immunologic adjuvant used in various vaccine products by GlaxoSmithKline (GSK). It is used, for example, in GSK's A/H1N1 pandemic flu vaccine Pandemrix. It is also in Arepanrix and the Q-pan for H5N1 influenza. [1] A dose of AS03 adjuvant contains [2] In the 2009 influenza ...
The U.S. government is to pay Sanofi and GlaxoSmithKline 2.1 billion dollars to cover vaccines for 50 million people. That works out at around 42 dollars per person inoculated. The award is the ...